1. Home
  2. SPRC

as of 08-13-2026 3:58pm EST

$6.66
$0.03
-0.45%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Founded: 2004 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 3.3M IPO Year: 2014
Target Price: N/A AVG Volume (30 days): 413.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.46 - $15.79 Next Earning Date: 04-24-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Stock Insider Trading Activity of SciSparc Ltd. (SPRC)

Sell
SPRC Jun 1, 2026

Avg Cost/Share

$10.00

Shares

462

Total Value

$4,620.00

Owned After

10,596

SEC Form 4

Share on Social Networks: